QU Quartr DIM: Sales and profit rose, guidance confirmed, with tariff effects and new product launches impacting results
Quartr
- Sources
- Quartr
- Markets
- Stocks
- Active symbols
- EURONEXT:DIM
- Language
- English
Sales revenue grew 6.4% in constant currencies, with strong recurring business and robust profitability. Management confirmed 2026 guidance, expecting 6–10% sales growth and a slightly higher EBITDA margin, despite tariff-related adjustments.Original document: Sartorius Stedim Biotech SA [DIM] Earn…
Sales revenue grew 6.4% in constant currencies, with strong recurring business and robust profitability. Management confirmed 2026 guidance, expecting 6–10% sales growth and a slightly higher EBITDA margin, despite tariff-related adjustments.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
